Paper42446728
Protein kinases as therapeutic targets in Alzheimer's disease: challenges, insights, and new frontiers.
Tak C and 2 others. Med Chem Res, 2026. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Protein kinases as therapeutic targets in Alzheimer's disease: challenges, insights, and new frontiers. Papers, record 42446728. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42446728
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Protein kinases as therapeutic targets in Alzheimer's disease: challenges, insights, and new frontiers.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Protein Kinases | Major topic |
| Protein Kinase Inhibitors | Major topic |
| Humans | |
| Animals | |
| tau Proteins | |
| Molecular Targeted Therapy |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| NRF-RS-2020-NR049583 (Center for Proteinopathy) | National Research Foundation of Korea grant | PubMed | PubMed | ||
| NRF-RS-2024-00333784 (J.-M.H.) | National Research Foundation of Korea | NRFRS202400 | PubMed | NIH RePORTER |
References127
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12615961 | GSK-3: tricks of the trade for a multi-tasking kinase. | J Cell Sci | 2003 | https://conductscience.org/library/papers/12615961 | PubMed |
| 2 | 15717052 | The blood-brain barrier and neurotherapeutics. | NeuroRx | 2005 | https://conductscience.org/library/papers/15717052 | PubMed |
| 3 | 22102280 | Evidence for irreversible inhibition of glycogen synthase kinase-3β by tideglusib. | J Biol Chem | 2012 | https://conductscience.org/library/papers/22102280 | PubMed |
| 4 | 23431164 | DLK initiates a transcriptional program that couples apoptotic and regenerative responses to axonal injury. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/23431164 | PubMed |
| 5 | 24904272 | GSK-3β, a pivotal kinase in Alzheimer disease. | Front Mol Neurosci | 2014 | https://conductscience.org/library/papers/24904272 | PubMed |
| 6 | 1789684 | Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. | Ann Neurol | 1991 | https://conductscience.org/library/papers/1789684 | PubMed |
| 7 | 12471243 | The protein kinase complement of the human genome. | Science | 2002 | https://conductscience.org/library/papers/12471243 | PubMed |
| 8 | 18798283 | The amino terminus of tau inhibits kinesin-dependent axonal transport: implications for filament toxicity. | J Neurosci Res | 2009 | https://conductscience.org/library/papers/18798283 | PubMed |
| 9 | 27354962 | Linking multiple pathogenic pathways in Alzheimer's disease. | World J Psychiatry | 2016 | https://conductscience.org/library/papers/27354962 | PubMed |
| 10 | 10696521 | Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms. | Clin Exp Pharmacol Physiol | 2000 | https://conductscience.org/library/papers/10696521 | PubMed |
| 11 | 11724784 | Jun NH2-terminal kinase (JNK) interacting protein 1 (JIP1) binds the cytoplasmic domain of the Alzheimer's beta-amyloid precursor protein (APP). | J Biol Chem | 2002 | https://conductscience.org/library/papers/11724784 | PubMed |
| 12 | 28257805 | JNK1 and JNK3 play a significant role in both neuronal apoptosis and necrosis. Evaluation based on in vitro approach using tert-butylhydroperoxide induced oxidative stress in neuro-2A cells and perturbation through 3-aminobenzamide. | Toxicol In Vitro | 2017 | https://conductscience.org/library/papers/28257805 | PubMed |
| 13 | 12606497 | Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo. | Diabetes | 2003 | https://conductscience.org/library/papers/12606497 | PubMed |
| 14 | 1759558 | Neuropathological stageing of Alzheimer-related changes. | Acta Neuropathol | 1991 | https://conductscience.org/library/papers/1759558 | PubMed |
| 15 | 39065802 | Computational Design of Novel Tau-Tubulin Kinase 1 Inhibitors for Neurodegenerative Diseases. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/39065802 | PubMed |
| 16 | 38401188 | Discovery of N-(5-amido-2-methylphenyl)-5-methylisoxazole-3-carboxamide as dual CSF-1R/c-Kit Inhibitors with improved stability and BBB permeability. | Eur J Med Chem | 2024 | https://conductscience.org/library/papers/38401188 | PubMed |
| 17 | 29863360 | Dual Leucine Zipper Kinase Inhibitors for the Treatment of Neurodegeneration. | J Med Chem | 2018 | https://conductscience.org/library/papers/29863360 | PubMed |
| 18 | 28440222 | Dual leucine zipper kinase-dependent PERK activation contributes to neuronal degeneration following insult. | Elife | 2017 | https://conductscience.org/library/papers/28440222 | PubMed |
| 19 | 33944571 | Discovery of Potent and Brain-Penetrant Tau Tubulin Kinase 1 (TTBK1) Inhibitors that Lower Tau Phosphorylation In Vivo. | J Med Chem | 2021 | https://conductscience.org/library/papers/33944571 | PubMed |
| 20 | 28099414 | Neurotoxic reactive astrocytes are induced by activated microglia. | Nature | 2017 | https://conductscience.org/library/papers/28099414 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42773735 | Phytochemical Analysis Using LC-MS/MS and Anticancer Activity of Asphodelus tenuifolius Roots: Cell Cycle Arrest, Apoptosis, and In Silico Insights. | Chem Biodivers | 2026 | https://conductscience.org/library/papers/42773735 | PubMed |
| 42749965 | Quercetin-Based Nanotherapeutics for Targeted Drug Delivery in Alzheimer's Disease: Comparative Insights into Molecular Mechanisms, Blood-Brain Barrier Targeting and Therapeutic Perspectives. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42749965 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 | NCBI Gene |
| CDK5 | 1020 | PubTator's text mining | https://conductscience.org/library/genes/1020 | NCBI Gene |
| CSF1R | 1436 | PubTator's text mining | https://conductscience.org/library/genes/1436 | NCBI Gene |
| FYN | 2534 | PubTator's text mining | https://conductscience.org/library/genes/2534 | NCBI Gene |
| GSK3B | 2932 | PubTator's text mining | https://conductscience.org/library/genes/2932 | NCBI Gene |
| MAP3K12 | 7786 | PubTator's text mining | https://conductscience.org/library/genes/7786 | NCBI Gene |
| MAPT | 4137 | PubTator's text mining | https://conductscience.org/library/genes/4137 | NCBI Gene |
| TTBK1 | 84630 | PubTator's text mining | https://conductscience.org/library/genes/84630 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42446728
GET https://conductscience.org/api/papers/v1/42446728/references?page=2